MEDIGESIC PLUS Drug Patent Profile
Which patents cover Medigesic Plus, and what generic alternatives are available?
Medigesic Plus is a drug marketed by Us Chem and is included in one NDA.
The generic ingredient in MEDIGESIC PLUS is acetaminophen; butalbital; caffeine. There is one drug master file entry for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MEDIGESIC PLUS?
- What are the global sales for MEDIGESIC PLUS?
- What is Average Wholesale Price for MEDIGESIC PLUS?
Summary for MEDIGESIC PLUS
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 8 |
| Patent Applications: | 122 |
| DailyMed Link: | MEDIGESIC PLUS at DailyMed |
US Patents and Regulatory Information for MEDIGESIC PLUS
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Us Chem | MEDIGESIC PLUS | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 089115-001 | Jan 14, 1986 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
